Actos Bladder Cancer

Causing Side Effects | Actos Attorney

Nadrich & Cohen is investigating Actos (Pioglitazone) victims in all 50 states who've been diagnosed with Bladder Cancer. Sadly, this diabetes drug has been linked to Bladder Cancer. On July 11, 2011, the French drug regulatory agency suspended the sale of Actos in France because of the bladder cancer risk . This action was taken after a large study of over 150,000 diabetic patients which compared individuals who used Actos (including the generic version) with those who did not. The study concluded that using a high dose of Actos over a period of one year or more greatly increases the risk of bladder cancer.

Unfortunately, Actos is still sold in the United States. In July 2011, the FDA issued a safety alert acknowledging the cancer link but did not restrict the sale of Actos or indicate it planned to withdraw Actos from the market.

The purpose of Actos is to maintain correct sugar levels. Its goal is to prevent the liver from producing more sugar than required and allow the efficient use of natural insulin which the liver produces.

Previous health warnings prior to bladder cancer included heart failure.

As a result of the European supension, the FDA issued a safety alert on June 15, 2011 commenting on the relationship between Actos and bladder cancer. Doctors were told not to prescribe Actos to patients who already have bladder cancer.

The FDA June 15, 2011 Safety Alert can be read here:

http://www.fda.gov/Drugs/DrugSafety/ucm259150.htm

On August 5, 2011, the FDA approved new labels for Actos including warnings of the bladder cancer risk.

We have gathered the most experienced, successful and qualified national Actos litigation team consisting of doctors, experts, trial lawyers, nurses and paralegals to take care of and assist our Actos bladder cancer clients. Our legal teams have recovered hundreds of millions of dollars in prescription drug litigation over the past fifteen years.

We would like to speak to you or your loved one if you have bladder cancer due to Actos. You can call an Actos bladder cancer side effect specialist today at 800-718-4658 or please complete the free case review on the right to find out if you or a loved one has an Actos lawsuit. With offices throughout California we are representing Actos victims in all 50 states. We spend every day fighting pharmaceutical companies and protecting the rights of Americans who are harmed by dangerous drugs and defective medical devices.

Bladder Cancer

A little bit about bladder cancer. Sadly, bladder cancer can be terminal. One out of four who are diagnosed with bladder cancer ultimately pass away.

We have extensive experience representing side effect drug victims against pharmaceutical companies. Our teams have the resources and knowledge necessary to win against the manufacturers. If you or a loved one has developed bladder cancer after taking Actos please contact our national law firm Nadrich & Cohen at 1-800-718-4658 for a free confidential consultation with an Actos intake specialist. There is no pressure. You will be happy you called. We will provide you with all the necessary knowledge, help and resources.

Please contact us today.

Our law firm handles cases throughout the entire United States including: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin and Wyoming.

Our lawyers and co-counsel also represent actively clients in the following cities: Los Angeles, San Diego, San Francisco, Fresno, Bakersfield, San Bernardino, Riverside, Sacramento, Santa Rosa, Santa Barbara, Santa Maria, Oxnard, Ventura, New York, Chicago, Houston, Phoenix, Philadelphia, San Antonio, El Paso, San Diego, Dallas, San Jose, Detroit, Jacksonville, Indianapolis, Salt Lake City, Reno, Las Vegas, Columbus, Austin, Memphis, Fort Worth, Baltimore, Washington D.C., Ann Arbor, Charlotte, Boston, Seattle, Pensacola, Orlando, Miami, Milwaukee, Seattle, Spokane, Salem, Oregon, Portland, Denver, Louisville, Nashville, Memphis, Oklahoma City, Albuquerque, Santa Fe, Phoenix, Tuscon, Portland, Atlanta, Long Beach, Mesa, Kansas City, Cleveland, Richmond, Omaha, Miami, Oakland, Tulsa, Honolulu, Minneapolis, Colorado Springs, Arlington, Wichita, Bismark, Boise.

Attorney Advertising – Trademark Notice: the use of the terms Actos® and actos®  are strictly for identification purposes and Attorney Advertising.  Actos® and actos® are registered trademarks of Takeda Pharmaceuticals.  Nadrich & Cohen LLP is in no way affiliated with Takeda Pharmaceuticals.